Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from National Institutes of Health

Alcohol use is widely accepted in the US, but even moderate consumption is associated with many harmful effects

This month, millions of Americans are taking part in “Dry January” in an effort to forgo alcohol for a month and cleanse themselves of the excesses of the holiday season.

The Conversation

Scientists explore using psychedelics to treat alcohol, drug disorders

LOS ANGELES — Melanie Senn's father, long dead, appeared to her as she lay back in the dimly lit room at the Santa Monica clinic, a mask over her closed eyes, and the psychedelic trip began.

Los Angeles Times

Fauci’s warning to America: ‘We’re living in a progressively anti-science era and that’s a very dangerous thing’

Dr. Anthony Fauci, who turns 82 on Saturday, wants the record to reflect that he is not retiring. Really, he isn’t. It’s just that after 54 years as a government scientist and adviser to seven presidents, he is leaving the National Institutes of Health at the end of the year.

Los Angeles Times

From analysis to the latest developments in health,
read the most diverse news in one place.

Loved or hated, Fauci’s parting advice: Stick to the science

Dr. Anthony Fauci is excited by the prospect of next-generation coronavirus vaccines but worried about health misinformation as he prepares to step down at the end of the month

The Independent UK

RSV treatments for young children are lacking, but the record 2022 cold and flu season highlights the urgency for vaccines and other preventive strategies

For many parents, respiratory syncytial virus – or RSV – which has been causing record numbers of hospitalizations of children during the fall of 2022, may sound like a relatively new and unheard-of threat. But in fact, RSV is a common respiratory virus that circulates every fall and winter and…

The Conversation

As viral infections skyrocket, masks are still a tried-and-true way to help keep yourself and others safe

The cold and flu season of 2022 has begun with a vengeance. Viruses that have been unusually scarce over the past three years are reappearing at remarkably high levels, sparking a “tripledemic” of COVID-19, the flu and respiratory syncytial virus, or RSV. This November’s national hospitalization levels for influenza were…

The Conversation

Lawsuit blames Fauci and federal agencies for Kansas City musician’s COVID-19 death

KANSAS CITY, Mo. — The widow of a popular Kansas City-area musician has filed a lawsuit accusing Dr. Anthony Fauci and the National Institutes of Health of indirectly causing her husband’s death from COVID-19 by funding coronavirus experimentation at a lab in China.

Tribune News Service

Read news from The Economist, FT, and more,
with one subscription

What is inflammation? Two immunologists explain how the body responds to everything from stings to vaccination and why it sometimes goes wrong

When your body fights off an infection, you develop a fever. If you have arthritis, your joints will hurt. If a bee stings your hand, your hand will swell up and become stiff. These are all manifestations of inflammation occurring in the body.

The Conversation

No prescription needed: over-the-counter hearing aids on sale in US

Hearing aids now available from stores including Walgreens and Walmart without prescription after new FDA rule takes effect

The Guardian - US

Texas researchers receive $149 million for large study of Alzheimer’s in racial, ethnic groups

FORT WORTH, Texas — The National Institutes of Health is giving $149 million to researchers at the University of North Texas Health Science Center to pay for researchers to study the biology of Alzheimer’s disease in multiple racial and ethnic groups.

Tribune News Service

Lab Monkeys Are the Latest Covid Shortage

Beijing’s ban on macaque exports—needed to test vaccines and other lifesaving drugs—could give its pharma industry an edge.

Businessweek

ARPA-H: High-risk, high-reward health research is the mandate of new, billion-dollar US agency

A new multibillion-dollar federal agency was created with a goal of supporting “the next generation of moonshots for health” in science, logistics, diversity and equality. And the agency now has it’s first leader, as President Joe Biden announced Renee Wegrzyn as director of the Advanced Research Projects Agency for Health,…

The Conversation

Will omicron-specific booster shots be more effective at combating COVID-19? 5 questions answered

On Sept. 1, 2022, the Centers for Disease Control and Prevention endorsed the use of updated COVID-19 booster shots that are specifically tailored to combat the two most prevalent omicron subvariants, BA.4 and BA.5. The decision comes just a day after the Food and Drug Administration’s emergency use authorization of…

The Conversation

Young adults are using marijuana and hallucinogens at the highest rates on record

The National Institutes of Health annually surveys substance abuse among young adults in its Monitoring the Future study.

WEKU

Get all your
news in one place.

100’s of premium titles.
One news app.

Inverse

We need to talk about "mild Covid" — and why it sucks

Early in the pandemic, doctors defined mild, moderate, and severe Covid. Two and a half years later, do they still make sense?

Benzinga

Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary

Avalo Therapeutics (NASDAQ:AVTX) has dosed the first patient in the pivotal LADDER trial to assess the efficacy and safety of AVTX-803 in Subjects with Leukocyte Adhesion Deficiency Type II (LAD II) ER). Avalo shares traded in a range of $3.5 to $3.91 on a day volume of 33.54 thousand shares,…

The Conversation

Cells become zombies when the ends of their chromosomes are damaged – a tactic both helpful and harmful for health

The Research Brief is a short take about interesting academic work.

The Independent UK

Biomedical grantmakers' diversity push gains new momentum

The Howard Hughes Medical Institute, one of the nation’s wealthiest philanthropies, announced a $1.5 billion effort designed to help scientists of color advance in their careers

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Efficacy Of Pfizer's Paxlovid COVID Drug Crashes, According To New NIH-Funded Study

A new National Institutes of Health (NIH) funded study sheds new light on the waning effectiveness of Pfizer’s (NYSE: PFE) Paxlovid to prevent patient hospitalizations due to COVID.

The Guardian - US

Anthony Fauci tests positive for Covid with mild symptoms

Biden’s chief medical adviser received two booster shots and is working from home, says National Institutes of Health

The Conversation

Why opting out of opioids can be dangerous in the operating room

Currently, patients in seven states can tell their physicians they don’t want to be treated with opioids in any health care setting, even during surgery. While unnecessary opioid exposure is a big reason behind the opioid epidemic in the U.S., we believe that non-opioid directives that allow patients to opt…

The Independent UK

Former longtime Illinois US Rep. John E. Porter dies at 87

Former Illinois U.S. Rep. John E

St. Louis Post-Dispatch

Researchers find that 2 drugs reduced COVID-19 deaths

ST. LOUIS — The National Institutes of Health released early results on of a trial involving Washington University, showing that two anti-inflammatory drugs reduced the risk of death in patients with severe COVID-19.

The Conversation

The lasting consequences of school shootings on the students who survive them

As the U.S. reels from another school shooting, much of the public discussion has centered on the lives lost: 19 children and two adults. Indeed, the massacre at Robb Elementary School in Uvalde, Texas is the second deadliest such incident on record, after the shooting at Sandy Hook Elementary School…

Benzinga

Why NRX Pharmaceuticals Shares Are Trading Lower During Premarket On Thursday?

Based on the review of approximately 460 patients, Data Safety and Monitoring Board (DSMB) determined that the evaluation of NRx Pharmaceuticals Inc's (NASDAQ:NRXP) Zyesami (aviptadil) should cease due to futility. Aviptadil was the sole remaining investigational medicine in ACTIV-3b targeted at critical-ill COVID-19 patients. ACTIV-3b study evaluated Zyesami and Gilead Sciences Inc's (NASDAQ:GILD) Veklury (remdesivir)…

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

University of Michigan

343 stories

Food and Drug Administration

325 stories

Science

294 stories

Centers for Disease Control and Prevention

279 stories

Gilead Sciences Inc

121 stories

Johns Hopkins University

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.